Page 6 - Cholangiocarcinoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cholangiocarcinoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cholangiocarcinoma Today - Breaking & Trending Today

Ventura County community rallies around beloved Santa Paula chef battling stage 4 cancer

Chef David Raigoza is known for serving those in need in Ventura County. The Santa Paula community is now rallying around him as he battles cancer. ....

Santa Paula , Santa Paulan , David Raigoza , Santa Paula Labor Day , Ventura County , Nancy Grass , Main Street , Deirdre Weaver , Chef David , David Raigoza , Stage 4 Cancer , Ventura County , Santa Paula , Labor Day Parade ,

Nuvectis Pharma Says FDA Grants Orphan Drug Designation To NXP800 For Cholangiocarcinoma

Biopharmaceutical company Nuvectis Pharma, Inc. (NVCT) announced Thursday that NXP800 was granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of cholangiocarcinoma. ....

United States , Nuvectis Pharma Inc , Drug Administration , Nuvectis Pharma , Orphan Drug Designation , Us Food And Drug Administration , Orphan Drug Designation , Nuvectis Pharma , Iopharmaceutical Company Nuvectis Pharma ,

Dr Borad on the Initial Efficacy of RLY-4008 in FGFR2 Fusion–Positive Cholangiocarcinoma

Mitesh Borad, MD, key findings from the phase 1/2 ReFocus trial in FGFR2-altered cholangiocarcinoma.
....

Mayo Clinic Comprehensive Cancer Center , Department Of Medical Oncology , Medical Oncology , Onclive Tv , Mayo Clinic , Rly 4008 , Fgfr2 Fusion ,

Pembrolizumab plus gemcitabine and cisplatin improves survival in advanced biliary tract cancer

1. Median overall survival was greater in the pembrolizumab group compared to the control group (12.7 months vs. 10.9 months). 2. Treatment-related adverse events were comparable among patients in either group. Evidence Rating Level: 1 (Excellent) Study Rundown: Biliary tract cancers are a complex group of epithelial tumors with a poor prognosis. The first-line therapy ....

Eastern Cooperative Oncology Group , Rating Level , Advanced Endometrial , Between Oct , Advanced Biliary Tract Cancer , Biliary Tract Cancer , Gastrointestinal Cancer , Hepatocellular Carcinoma , Chronic Disease ,

DelveInsight Business Research, LLP: Cholangiocarcinoma Clinical Trial Pipeline Analysis Demonstrates 65+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The prevalence of cholangiocarcinoma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cholangiocarcinoma and the ....

United States , Mecklenburg Vorpommern , Kinnate Biopharma , Wellmarker Bio , Stefan Klotter , Genoscience Pharma , Shruti Thakur , Senhwa Biosciences , Nuvectis Pharma , Innocare Pharma , Richard Kim , Invitae Ciitizen , Redhill Biopharma , Eli Lilly , Basilea Pharmaceutica , Hutchison Medipharma , Toray Industries Inc , Healthcare Competitive Intelligence Services , Taiho Oncology Inc , Janssen Research Development , American Association For Cancer Research , Healthcare Services , Delcath Systems Inc , Transthera Sciences , Market Research , Newish Technology Beijing Co Ltd ,